Donor Specific Anti-HLA Antibody and Risk of Graft Failure in Haploidentical Stem Cell Transplantation

Donor Specific Anti-HLA Antibody and Risk of Graft Failure in Haploidentical Stem Cell Transplantation

Outcomes of allogeneic hematopoietic stem cell transplantation (AHSCT) using HLA-half matched related donors (haploidentical) have recently improved due to better control of alloreactive reactions in both graft-versus-host and host-versus-graft directions. The recognition of the role of humoral reje...

Full description

Saved in:

Bibliographic Details
Main Authors:	Piyanuch Kongtim, Kai Cao, Stefan O. Ciurea
Format:	Article
Language:	English
Published:	Wiley 2016-01-01
Series:	Advances in Hematology
Online Access:	http://dx.doi.org/10.1155/2016/4025073
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Haploidentical Stem Cell Transplantation: A Gateway to Infrequent Availability of HLA-Matched Related Donors
by: Hafiz Muhammad Aslam, et al.
Published: (2018-01-01)

Donor-Specific Anti-Human Leukocyte Antigen Antibodies Predict Prolonged Isolated Thrombocytopenia and Inferior Outcomes of Haploidentical Hematopoietic Stem Cell Transplantation
by: Xiaosu Zhao, et al.
Published: (2017-01-01)

Haploidentical Family Donor Transplantation: At the Crossroads of a Changing Paradigm
by: Suparno Chakrabarti, et al.
Published: (2016-01-01)

The Combination of Intravenous Immunoglobulin, Dexamethasone, and a High Dose of Mononuclear Cells Transfusion: An Effective Strategy for Decreasing Donor-Specific Antibodies During Haploidentical Hematopoietic Stem Cell Transplantation
by: Xiaoping Li, et al.
Published: (2025-01-01)

Improving Cytomegalovirus-Specific T Cell Reconstitution after Haploidentical Stem Cell Transplantation
by: Xiao-Hua Luo, et al.
Published: (2014-01-01)

Cerebellar Neurocysticercosis as Long-Term Complication of Allogeneic Haematopoietic Stem Cell Transplantation from Haploidentical Donor
by: Federico Meconi, et al.
Published: (2019-01-01)

Predicted indirectly recognizable HLA epitopes scores and clinical outcomes after haploidentical stem cell transplantation in pediatric patients with relapsed neuroblastoma
by: Eun Seop Seo, et al.
Published: (2025-01-01)

Corrigendum: Predicted indirectly recognizable HLA epitopes scores and clinical outcomes after haploidentical stem cell transplantation in pediatric patients with relapsed neuroblastoma
by: Eun Seop Seo, et al.
Published: (2025-02-01)

A Phase II Trial of Melphalan Based Reduced-Intensity Conditioning for Transplantation of T-Replete HLA-Haploidentical Peripheral Blood Stem Cells with Posttransplant Cyclophosphamide in Patients with Hematologic Malignancies
by: Melhem M. Solh, et al.
Published: (2021-01-01)

The Humoral Theory of Transplantation: Epitope Analysis and the Pathogenicity of HLA Antibodies
by: Edward J. Filippone, et al.
Published: (2016-01-01)

Incidence and Clinical Significance of De Novo Donor Specific Antibodies after Kidney Transplantation
by: Sophia Lionaki, et al.
Published: (2013-01-01)

Role of Anti-MICA Antibodies in Graft Survival of Renal Transplant Recipients of India
by: Mohit Chowdhry, et al.
Published: (2018-01-01)

Choice of Unmanipulated T Cell Replete Graft for Haploidentical Stem Cell Transplant and Posttransplant Cyclophosphamide in Hematologic Malignancies in Adults: Peripheral Blood or Bone Marrow—Review of Published Literature
by: Shatha Farhan, et al.
Published: (2016-01-01)

Haploidentical stem cell transplantation with posttransplant cyclophosphamide in children with Wiskott–Aldrich syndrome: a case report
by: Le Nguyen Ngoc Quynh, et al.
Published: (2025-02-01)

γδ T Cells’ Role in Donor-Specific Antibody Generation: Insights From Transplant Recipients and Experimental Models
by: Xavier Charmetant, et al.
Published: (2025-01-01)

Review on Haploidentical Hematopoietic Cell Transplantation in Patients with Hematologic Malignancies
by: William A. Fabricius, et al.
Published: (2016-01-01)

Clinical Outcomes and Donor-specific Antibody Rebound 5 y After Kidney Transplant Enabled by Imlifidase Desensitization
by: Ian S. Jaffe, BS, et al.
Published: (2025-02-01)

Haploidentical hematopoietic stem cell transplantation using post-transplant cyclophosphamide in patients with inborn errors of immunity: Experience in a reference center in Colombia
by: Diego Medina, et al.
Published: (2024-12-01)

Significance of Semiquantitative Assessment of Preformed Donor-Specific Antibody Using Luminex Single Bead Assay in Living Related Liver Transplantation
by: Atsushi Yoshizawa, et al.
Published: (2013-01-01)

Occurrence of Fatal and Nonfatal Adverse Outcomes after Heart Transplantation in Patients with Pretransplant Noncytotoxic HLA Antibodies
by: Luciano Potena, et al.
Published: (2013-01-01)

Middle hepatic vein incorporation in live donor liver graft transplantation; implication and safety
by: Mahmoud Ali Abdi, et al.
Published: (2021-08-01)

HAPLOIDENTICAL TRANSPLANT WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE FOR ACUTE MYELOID LEUKAEMIA AND MYELODYSPLASTIC SYNDROMES PATIENTS: THE ROLE OF PREVIOUS LINES OF THERAPY.
by: Daniele Avenoso, et al.
Published: (2024-01-01)

e-GLR Score Predicts Early Graft Loss in Adult Live-Donor Liver Transplantation
by: Viniyendra Pamecha, MS, MRCS, FRCS, FEBS, et al.
Published: (2023-12-01)

The effect of low donor-to-recipient body weight ratio on graft survival after dual kidney transplantation from pediatric deceased donors
by: Mingchuan Huang, et al.
Published: (2025-12-01)

HLA Haplotype Mismatch Transplants and Posttransplant Cyclophosphamide
by: Andrea Bacigalupo, et al.
Published: (2016-01-01)

Shorter Digestion Times of Donor Islets Is Associated With Better Islet Graft Function After Islet Transplantation
by: Chia-Hao Wang, et al.
Published: (2025-01-01)

Risk factors and clinical outcomes of cytomegalovirus infection following haploidentical hematopoietic stem cell transplantation in patients with aplastic anemia: a single-center retrospective study
by: Jia Feng, et al.
Published: (2025-01-01)

Donor Selection for Allogenic Hemopoietic Stem Cell Transplantation: Clinical and Ethical Considerations
by: Irene Riezzo, et al.
Published: (2017-01-01)

Safety and Tolerance of Donor-Derived Mesenchymal Stem Cells in Pediatric Living-Donor Liver Transplantation: The MYSTEP1 Study
by: Steffen Hartleif, et al.
Published: (2017-01-01)

HLA-G as a Tolerogenic Molecule in Transplantation and Pregnancy
by: Vera Rebmann, et al.
Published: (2014-01-01)

Anti-HEV antibody reactivity rate in voluntary blood donors in China: a Meta-analysis
by: XU Niuniu, et al.
Published: (2025-01-01)

Decoding the Molecular Basis of the Specificity of an Anti-sTn Antibody
by: Cátia O. Soares, et al.
Published: (2024-12-01)

Discrimination of Anti-Donor Response in Allogeneic Transplantation Using an Alloreactive T-Cell Detection Assay
by: Ryosuke Arata, et al.
Published: (2025-01-01)

Time-Zero Biopsies in Deceased-Donor Kidney Transplantation: Predictive Value of Histological Findings on Long-Term Graft Function
by: Bárbara Beirão, et al.
Published: (2025-02-01)

Fecal microbiota transplantation to prevent acute graft-versus-host disease: pre-planned interim analysis of donor effect
by: Swetha Reddi, et al.
Published: (2025-01-01)

Understanding HLA-DQ in renal transplantation: a mini-review
by: Rajdeep Das, et al.
Published: (2025-02-01)

Control of BKPyV-DNAemia by a Tailored Viro-Immunologic Approach Does Not Lead to BKPyV-Nephropathy Progression and Development of Donor-Specific Antibodies in Pediatric Kidney Transplantation
by: Michela Cioni, et al.
Published: (2024-12-01)

Chronic Hepatitis E Infection Resulting in Graft Failure in a Liver Transplant Tourist
by: Hui-Hui Tan, et al.
Published: (2011-01-01)

Liver Transplantation Using a Graft from a Donor with Situs Inversus Totalis: A Case Report and Review of the Literature
by: Xu-Yong Sun, et al.
Published: (2013-01-01)

Prognostic impact of donor mitochondrial genomic variants in myelodysplastic neoplasms after stem-cell transplantation
by: Jing Dong, et al.
Published: (2024-11-01)